perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/bwga...
TRANSCRIPT
![Page 1: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/1.jpg)
Perioperative antiplatelet therapymanagement
Dr Borgoens Philippe
Cardiologist
CHR Citadelle Liège
![Page 2: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/2.jpg)
Perioperative antiplatelet therapy management
• 1 000 000 patients undergo coronary stent implantation per year in UE and USA
• 15% and 25% patients undergo invasive or surgical procedurewithin 1 and 5 y post coronary stenting
![Page 3: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/3.jpg)
![Page 4: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/4.jpg)
![Page 5: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/5.jpg)
Urgent surgery
• Surgery required within 48h
• Avoid platelets transfusion 4-6h after thienopyridine and 10-12 h after last intake ticagrelor
![Page 6: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/6.jpg)
Thrombotic risk in elective surgery
![Page 7: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/7.jpg)
![Page 8: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/8.jpg)
Optimal antiplatelet therapy CAD
![Page 9: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/9.jpg)
![Page 10: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/10.jpg)
![Page 11: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/11.jpg)
Optimal antiplatelet therapy PAD
![Page 12: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/12.jpg)
Not only cardiologist point of view…Multidisciplinar approach…
![Page 13: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/13.jpg)
https://itunes.apple.com/us/app/stent-surgery/id551350096?mt=8.
GIHP 2017
![Page 14: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/14.jpg)
Stent <1moStent for MI<6moStent increased ischemic risk <6m
---> HIGH THROMBOTIC RISK
Adapted from GIHP consensus 2017 and Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 15: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/15.jpg)
Hemorrhagic risk and surgery
• LOW: DAPT →continue
• INTERMEDIATE: ASPIRIN →continue
• HIGH: ASPIRIN → stop (very high risk)
![Page 16: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/16.jpg)
Aspirin or P2Y12- monotherapy
Low intermediate high
Primary preventionASA
stop stop stop
Secondaryprevention
ASA or Clopidogrel
continue Continue ASAStop clopidogrel 7d and start ASA
(Stop aspirin 3-5d)Stop clopidogrel 5d+2d if intracranialsurgeryBe carefull si CVA or TIA<1m, CABG<6w
Hemorrhagic risk
Adapted from GIHP consensus 2017
![Page 17: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/17.jpg)
LOW INTERMEDIATE HIGH
LOW AspirinP2Y12-
AspirinP2Y12-
AspirinP2Y12-
INTERMEDIATE AspirinP2Y12-
AspirinP2Y12-
If nondeferrable
AspirinP2Y12-
If nondeferrable(IIbIIIa -?)
HIGH AspirinP2Y12-
(Aspirin)P2Y12-
If nondeferrable
((Aspirin))P2Y12-
If nondeferrable(IIbIIIa -?)
Thrombotic risk
Bleeding
Bitherapy
POSTPONE INTERVENTION IF POSSIBLE
Adapted from GIHP consensus 2017 and Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
ContinueStop
![Page 18: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/18.jpg)
Prasugrel 7d, Clopidogrel 5d, Ticagrelor (3 -5d), ASA 3dIf intracanian surgery: +2 d for all GIHP french consensus 2017
![Page 19: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/19.jpg)
![Page 20: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/20.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 21: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/21.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 22: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/22.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 23: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/23.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 24: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/24.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 25: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/25.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 26: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/26.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 27: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/27.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 28: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/28.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 29: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/29.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 30: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/30.jpg)
Rossini and al, JACC cardiovascular interventions Vol 11 NO S 2018 March 12 2018 4 17-34
![Page 31: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/31.jpg)
![Page 32: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/32.jpg)
![Page 33: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/33.jpg)
![Page 34: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/34.jpg)
![Page 35: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/35.jpg)
• ♂ 75 yo
• PCI DES RCA 3 m ago for ACS
• PCI LAD 5 y ago for stable angina
• GFR 40ml/min
• Diabetes type II
• Asa 100mg od, Brilique 90mg bid
• Acute lithiasic non perforated cholecystis. No septic shock, no migration
![Page 36: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/36.jpg)
Question
1. Stop Brilique 3 d, continue ASA for cholecystectomy
2. Stop Brilique 7 d, continue ASA for cholecystectomy
3. Stop Brilique 5 d, stop ASA 3d for cholecystectomy
4. Continue aspirine and Brilique for cholecystectomy
5. Postpone surgery with antibiotics to at least 1y post ACS
![Page 37: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/37.jpg)
Question
1. Stop Brilique 3 d, continue ASA for cholecystectomy
2. Stop Brilique 7 d, continue ASA for cholecystectomy
3. Stop Brilique 5 d, stop ASA 3d for cholecystectomy
4. Continue aspirine and Brilique for cholecystectomy
5. Postpone surgery with antibiotics to at least 1y post ACS
![Page 38: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/38.jpg)
Complication…
• Choledochal lithiasis migration and acute pancreatitis
-> non deferrable ERCP + sphincterotomy
![Page 39: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/39.jpg)
Question
1. Stop Brilique 3 d, continue ASA
2. Stop Brilique 7 d, continue ASA
3. Stop Brilique 5 d, stop ASA 3d
4. Stop Brilique 3d, stop ASA 3d
5. Stop Brilique 5d, continue ASA
6. Stop Brilique 5d, continue ASA, start IIbIIIa inhibitor
7. Stop Brilique, continue ASA, start LWMH
![Page 40: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/40.jpg)
Questions
1. Stop Brilique 3 d, continue ASA
2. Stop Brilique 7 d, continue ASA
3. Stop Brilique 5 d, stop ASA 3d
4. Stop Brilique 3d, stop ASA 3d
5. Stop Brilique 5d, continue ASA
6. Stop Brilique 5d, continue ASA, start IIbIIIa inhibitor
7. Stop Brilique, continue ASA, start LWMH
![Page 41: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/41.jpg)
Digestive endoscopy
![Page 42: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/42.jpg)
• ♀ 65 yo
• DES LAD for STEMI 2 m ago
• Efient 10mg od, ASA 100mg od
• Discovery malignant brain’s tumor
-> intracranial surgery
![Page 43: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/43.jpg)
Question
1. Stop ASA 5 days and Efient 7 days
2. Continue ASA and stop Efient 7days
3. Stop ASA 7 days, Efient 7 days and bridge LWMH
4. Stop ASA 5 days and Efient 7 days, bridge IIbIIIa inhibitors 3 days before->4h before surgery
![Page 44: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/44.jpg)
Question
1. Stop ASA 5 days and Efient 7 days
2. Continue ASA and stop Efient 7days
3. Stop ASA 7 days, Efient 7 days and bridge LWMH
4. Stop ASA 5 days and Efient 7 days, bridge IIbIIIa inhibitors 3 days before->4h before surgery
![Page 45: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/45.jpg)
Neurosurgery
![Page 46: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/46.jpg)
• ♂68yo
• 2 DES proximal LAD and proximal CX for stable angina 5m ago
• STEMI PCI RCA 5y ago
• LVEF 50%
• Clopidogrel, ASA
• Anemia 9,6gr/l
• Gastroscopy and coloscopy…
![Page 47: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/47.jpg)
Question
1. Stop clopidogrel 5 d continue ASA
2. Stop clopidogrel 7d and stop ASA 3 d
3. Stop ASA 3d, continue clopidogrel
4. Continue clopidogrel and ASA
5. Postpone exams
![Page 48: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/48.jpg)
Question
1. Stop clopidogrel 5 d continue ASA
2. Stop clopidogrel 7d and stop ASA 3 d
3. Stop ASA 3d, continue clopidogrel
4. Continue clopidogrel and ASA
5. Postpone exams
![Page 49: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/49.jpg)
Digestive endoscopy
![Page 50: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/50.jpg)
• ♂68yo
• BMS PTA iliac 2m ago
• Clopidogrel ASA
• Prostatic cancer -> radical prostatectomy
![Page 51: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/51.jpg)
Question
1. Stop clopidogrel 7d and continue ASA
2. Continue clopidogrel ASA
3. Stop clopidogrel 5d and continue ASA
4. Stop clopidogrel 5 d and stop ASA 3d
5. Stop clopidogrel 5d and ASA 5d
6. Stop clopidogrel 5d and ASA 7d
![Page 52: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/52.jpg)
Question
1. Stop clopidogrel 7d and continue ASA
2. Continue clopidogrel ASA
3. Stop clopidogrel 5d and continue ASA
4. Stop clopidogrel 5 d and stop ASA 3d
5. Stop clopidogrel 5d and ASA 5d
6. Stop clopidogrel 5d and ASA 7d
![Page 53: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/53.jpg)
![Page 54: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/54.jpg)
• ♀ 75 yo
• Carotid endarterectomy 1 y ago for stroke and limb amputation 6 m ago
• Clopidogrel 75mg od
• Gastric cancer ->gastrectomy
![Page 55: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/55.jpg)
Question
1. Stop clopidogrel 5d
2. Continue clopidogrel
3. Stop clopidrogel 7d and start aspirin, continue aspirin
4. Stop clopidogrel 7d
![Page 56: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/56.jpg)
Question
1. Stop clopidogrel 5d
2. Continue clopidogrel
3. Stop clopidrogel 7d and start aspirin, continue aspirin
4. Stop clopidogrel 7d
![Page 57: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/57.jpg)
![Page 58: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/58.jpg)
• ♀75 yo
• Stable angina and multivessels disease
• No history MI
• Aspirin
-> CABG
![Page 59: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/59.jpg)
Question
1. Stop ASA 3d
2. Stop ASA 5d
3. Continue ASA
4. Stop ASA 7d
5. Stop ASA 10d
![Page 60: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/60.jpg)
Question
1. Stop ASA 3d
2. Stop ASA 5d
3. Continue ASA
4. Stop ASA 7d
5. Stop ASA 10d
![Page 61: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/61.jpg)
![Page 62: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/62.jpg)
Management of antithrombotic therapy in patients
undergoing elective invasive procedures
Serge Motte
– 21.04.18 -
![Page 63: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/63.jpg)
ANTICOAGULANTS
63
Fondaparinux
DanaparoïdeXa
IIa
TF/VIIa
X IX
IXa
VIIIa
FibrineFibrinogène
AT
Adapté de Weitz & Bates, J Thromb Haemost 2005
Héparines
AT
AT
AVK [II,VII,IX,X]
Rivaroxaban(Xarelto®)
Apixaban(Eliquis®)
Edoxaban(Lixiana®)
Dabigatran(Pradaxa®)
![Page 64: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/64.jpg)
MANAGEMENT OF ANTITHROMBOTIC THERAPY IN PATIENTS
UNDERGOING ELECTIVE INVASIVE PROCEDURES
64
Case 1
76 year-old female
Associated diseases:
Hypertension
Diabetes non-insulin treated
Moderate renal insufficiency (CrCL: 55 ml/min. )
Atrial fibrillation since 10 years, treated with
Sintrom®
Changes in bowel behavior
Planned colonoscopy
![Page 65: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/65.jpg)
MANAGEMENT OF ANTITHROMBOTIC THERAPY IN PATIENTS
UNDERGOING ELECTIVE INVASIVE PROCEDURES
Last intake of Sintrom® on D – 4 and bridging with
therapeutic dose of LMWH
Last intake of Sintrom® on D – 4 and bridging with
prophylactic dose of LMWH
Last intake of Sintrom® on D – 4 and no bridging
Continue Sintrom®, monitor the INR and carry out
the colonoscopy with INR 1,5-2,0
Last intake of Sintrom® on D – 4 and bridging with
therapeutic dose of unfractionated heparin
65
Which option ?
![Page 66: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/66.jpg)
ANTICOAGULANT TREATMENT AND PLANNED INVASIVE PROCEDURES:
WHAT ARE THE RISKS?
66
![Page 67: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/67.jpg)
ANTICOAGULANT TREATMENT AND PLANNED INVASIVE
PROCEDURES: WHAT ARE THE RISKS?
67Rechenmacher SJ et Fang JC. J Am Coll Cardiol 2015;66:1392–403
Periprocedural event rates by oral anticoagulation indication
![Page 68: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/68.jpg)
MANAGEMENT OF AF PATIENTS:
TO BRIDGE OR NOT TO BRIDGE ?
The BRIDGE study: 1884 AF patients
68JD Douketis et al. N Engl J Med. 2015;373:823-33
* P value for non inferiority; † P value for superiority.
![Page 69: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/69.jpg)
BRIDGING RESULTS IN PERIPROCEDURAL BLEEDING WITHOUT
REDUCTION IN THROMBOEMBOLISM
69Rechenmacher SJ et Fang JC. J Am Coll Cardiol 2015;66:1392–403
Periprocedural event rates by bridging strategy
![Page 70: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/70.jpg)
IN CLINICAL PRACTICE
In patients treated with VKAs:
Individualized bridging anticoagulation in specific high-
risk patients with a low bleeding risk procedure
70
![Page 71: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/71.jpg)
WHICH PATIENTS ARE AT HIGH RISK OF THROMBOEMBOLISM
IN CASE OF TEMPORARY INTERRUPTION OF ORAL
ANTICOAGULATION ?
Mechanical mitral heart valve
Multiple mechanical heart valves
Mechanical aortic heart valve and additional risk
factors (history of thromboembolism, AF, heart failure,
dilated cardiomyopathy, intracardiac thrombus)
AF with history of stroke or TIA, left atrial appendage
thrombus
Venous thromboembolism 3 months
71
![Page 72: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/72.jpg)
PROCEDURES CARRYING A HIGH RISK OF BLEEDING
Cardia surgery, major vascular surgery
Neurosurgery
Major surgery for cancer
Urology surgery: prostatectomy, nephrostomy,
nephrectomy, cystectomy
Colonoscopy with polypectomy
Endoscopic sphincterotomy
Vitrectomy, blepharoplasty,..
72
![Page 73: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/73.jpg)
EXAMPLE OF ALGORITHM FOR THE MANAGEMENT OF
SINTROM®
73
High risk of thromboembolism?
Last intake of Sintrom® on D – 4
Yes
No bridging
No
Start Clexane when INR < 2**
Last dose 24 h
before procedure
Yes No
ClCR < 30 ml/min*
Start UFH when INR < 2**
Stop 6 h before procedure
** In practice, start D - 2
Clexane 1 mg/kg/12h; UFH iv , 15 UI/kg/h (no bolus)
![Page 74: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/74.jpg)
EXAMPLE OF ALGORITHM FOR THE MANAGEMENT OF
SINTROM®
74
High risk of thromboembolism ?
After the procédure
Yes
No bridging
No
Start Sintrom J0 ou
later post-procédure
according to
bleeding risk
High risk of bleeding ?
Yes No
No Clexane or UFH
Start Sintrom J1 post-procedure
or later according to bleeding risk
Start Clexane SC 24 h ou
UFH IV 12 h after procedure*
Start Sintrom J0 or
J1 post-procedure
* Clexane 1 mg/kg/12 h
iv UFH : pre-op maintenance dose (no bolus)
![Page 75: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/75.jpg)
MANAGEMENT OF ANTITHROMBOTIC THERAPY IN
PATIENTS UNDERGOING ELECTIVE INVASIVE PROCEDURES
Case 2
72 year-old male
Associated diseases:
Hypertension
Obesity (BMI 33 kg/m2)
Urinary catheter recently placed for acute urinary retention
Planned open surgery for large benign prostate adenoma
Diagnosis of proximal DVP, 2 weeks ago, treatmentwith Xarelto®
75
![Page 76: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/76.jpg)
MANAGEMENT OF ANTITHROMBOTIC THERAPY IN PATIENTS
UNDERGOING ELECTIVE INVASIVE PROCEDURES
Last intake of Xarelto® on D – 3 and bridging with
therapeutic dose of LMWH
Last intake of Xarelto® on D – 3 and bridging with
prophylactic dose of LMWH
Last intake of Xarelto® on D – 3 and no bridging
Postpone surgery up to 3 months of anticoagulant
therapy
76
Which option ?
![Page 77: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/77.jpg)
DIRECT ORAL ANTICOAGULANTS
MAIN PHARMACOKINETIC CHARACTERISTICS
77
CharacteristicsDabigatran
(Pradaxa®)
Rivaroxaban
(Xarelto®)
Apixaban
(Eliquis®)
Edoxaban
(Lixiana®)
T Cmax (h) 2 2-4 1-4 1-2
Half-life 14 à 17 h 7 à 13 h 10 à 14 h 9 à 11h
Renal elimination 80% 35% 27% 50%
![Page 78: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/78.jpg)
EXAMPLE OF ALGORITHM FOR THE MANAGEMENT OF
PRADAXA® (DABIGATRAN)
78
Yes No
Restart 48 h-72 h after procedure
according to bleeding riskRestart 24 h after procedure
Last intake before procedure according ClCR
> 80 ml/min: 3 days 50 - 80 ml/min: 3 - 4 days > 30 - 50 ml/min: 5 days
Last intake before procedure according ClCR
> 80 ml/min: 2 days50 - 80 ml/min: 2 - 3 days > 30 - 50 ml/min: 3 - 4 day
High risk of bleeding ?
![Page 79: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/79.jpg)
79
Yes No
Restart Anti-Xa 48 h-72 h after
procedure according to bleeding riskRestart Anti-Xa 24 h after procedure
Last intake 72 h before procedure Last intake 48 h before procedure
High risk of bleeding or
age > 75 years or ClCR < 50 ml/min ?
EXAMPLE OF ALGORITHM FOR THE MANAGEMENT OF
XA INHIBITORS
![Page 80: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/80.jpg)
CONCLUSIONS 1
80
Periprocedural anticoagulation management often
leads to significant adverse events Bleeding is much more common than clotting
Bridging in patients treated with VKAs results in
periprocedural bleeding without reduction in
thromboembolism
80
![Page 81: Perioperative antiplatelet therapy management - angiology.beangiology.be/onewebmedia/BWGA 2018_Workshop_Gestion péri-opératoire... · later post-procédure according to bleeding](https://reader030.vdocuments.us/reader030/viewer/2022040702/5d63314a88c993ea6a8b8f46/html5/thumbnails/81.jpg)
CONCLUSIONS 2
In patients treated with VKAs:
Individualized bridging anticoagulation in specific high-risk
patients with a low bleeding risk procedure
In patients treated with DOACs:
No bridging unless oral anticoagulation resumption is
delayed after the procedure
81